‌

US Patent 8912335 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Patent 8912335 was granted and assigned to Metabolic Solutions Development Company on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Metabolic Solutions Development Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8912335

Date of Patent

December 16, 2014

Patent Application Number

13515508

Date Filed

December 15, 2010

Patent Primary Examiner

‌

Patricia L Morris

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8912335 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API